SAVE THE DATE
3rd Cologne Conference on Lung Cancer (#CCLC2025) is scheduled to take place on June 26th and 27th, 2025 at the Maritim Hotel in Cologne. Co-Chair Carolin Dive from Cancer Research UK Manchester Institute #cologne#lungcancer#conference
Happy to have Professor Carolin Dive from Cancer Research UK as chair @CCLC2024! The position will make this a key event - we are looking forward to it !
Throwback CCLC 2019:
Session with Carolin Dive about circulating tumor cells in SCLC
Finally - SAVE THE DATE
3rd Cologne Conference on Lung Cancer
27./28.6.2024
Cologne, Germany
Conference Chair 2024:
Carolin Dive, Roman Thomas, Reinhard Büttner, Jürgen Wolf
See you there! #CCLC#nngm#lungcancer
Further information will follow soon..
In our research on small-scale #ROS1 mutations in #NSCLC now out @LungCaJournal we showed:
-clinical characteristics opposing #ROS1 fusions
-heterogeneous functional impact
-significant benefit from #Immunotherapy@ros1cancer
https://t.co/7Cse4HbS7z
A thread 1/7
Not only glucose.. Amminoacids (serine) and unsaturated/saturated fatty acids balance does matter in controlling tumor growth. Great talk from @LabVousden#AACR21@OncoAlert
Friends,
An incredible honour to publish our work on the “Impact of #COVID19 on social media as perceived by the oncology community” now out on @ESMO_Open
This was an amazing Collaboration by @myESMO LGP group, ESMO SoMe WG & the @OncoAlert 🚨Network‼️
https://t.co/eAFMEylaLm
The #ELCC21 Congress is about to start and we will have our #YOC VIRTUAL LOUNGE DISCUSSIONS.
Virtual Lounges are #networking areas where u can meet peers & experts during breaks & outside official program times. Join us there :) https://t.co/D5oluOwzYr
Our work on a novel small-molecule drug, the SOS1::KRAS inhibitor BI-3406, which targets KRAS-addicted cancers, is now published & formatted in the January 2021 issue of Cancer Discovery @CD_AACR - https://t.co/JtwNf5wMXS @MarcoHHofmann@norbertkraut1@timheff5@Boehringer